Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Final height and endocrine function in thalassaemia intermedia.

V De Sanctis1, A Tangerini, M R Testa

  • 1Department of Paediatrics and Adolescent Medicine, Arcispedale S. Anna, Ferrara, Italy.

Journal of Pediatric Endocrinology & Metabolism : JPEM
|March 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive factors of response in lung metastases treated by sbrt from colon rectal cancer.

Clinical & experimental metastasis·2026
Same author

Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy.

Clinical & experimental metastasis·2024
Same author

Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO).

Clinical and translational radiation oncology·2023
Same author

GH/IGF-1 axis in a large cohort of ß-thalassemia major adult patients: a cross-sectional study.

Journal of endocrinological investigation·2022
Same author

Erratum to "30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease" [Lung Cancer 122 (2018) 165-170].

Lung cancer (Amsterdam, Netherlands)·2021
Same author

A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021

Endocrine dysfunction, including delayed puberty and hypogonadism, is common in adults with beta-thalassaemia intermedia. Regular endocrine screening is crucial for early detection and management of these conditions.

Area of Science:

  • Endocrinology
  • Hematology

Background:

  • Beta-thalassaemia intermedia is a chronic blood disorder requiring lifelong management.
  • Patients often have iron overload due to transfusions and chelation therapy, impacting endocrine organs.

Purpose of the Study:

  • To investigate the prevalence and characteristics of endocrine dysfunction in adults with beta-thalassaemia intermedia.
  • To identify specific endocrine abnormalities and their potential causes.

Main Methods:

  • Cross-sectional study of 50 adult patients (21 males, 29 females) with beta-thalassaemia intermedia.
  • Assessment of endocrine function including gonadal, pituitary, thyroid, and glucose metabolism.
  • Analysis of clinical data, transfusion history, and chelation therapy.

Related Experiment Videos

Main Results:

  • Delayed puberty (36%) was the most frequent abnormality. Hypogonadism was observed in 2 males and 4 females with secondary amenorrhea.
  • Pituitary dysfunction suggested by poor response to GnRH in hypogonadal patients.
  • Glucose intolerance (24%) and hypothyroidism (5.7%) were less frequent and milder than in thalassaemia major.

Conclusions:

  • Adults with beta-thalassaemia intermedia frequently experience endocrine abnormalities, particularly affecting puberty and gonadal function.
  • Periodic endocrine evaluation, especially in those over 14 years, is recommended for early detection and management.
  • Findings suggest a need for tailored endocrine monitoring in beta-thalassaemia intermedia management.